Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.58 USD | +3.50% | -3.65% | +86.16% |
24/06 | Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index | CI |
21/06 | Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+86.16% | 738M | |
+55.55% | 816B | |
+39.71% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.25% | 238B | |
+0.98% | 222B | |
+13.40% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- Harrow Health : B. Riley Resumes Harrow Health at Buy with $16 PT, Says Well-Positioned to Maintain Momentum with Recent Q2 Beat, M&A Execution